Texas Capital Bancshares Inc TX Lowers Stake in Danaher Corporation $DHR

Texas Capital Bancshares Inc TX lowered its holdings in shares of Danaher Corporation (NYSE:DHR) by 83.7% during the 3rd quarter, HoldingsChannel reports. The fund owned 606 shares of the conglomerate’s stock after selling 3,108 shares during the period. Texas Capital Bancshares Inc TX’s holdings in Danaher were worth $120,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Sivia Capital Partners LLC lifted its holdings in shares of Danaher by 6.3% during the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock valued at $397,000 after purchasing an additional 119 shares during the last quarter. Los Angeles Capital Management LLC grew its stake in shares of Danaher by 2.2% in the 2nd quarter. Los Angeles Capital Management LLC now owns 3,297 shares of the conglomerate’s stock worth $651,000 after buying an additional 71 shares during the last quarter. Allworth Financial LP increased its position in Danaher by 12.2% during the 2nd quarter. Allworth Financial LP now owns 5,099 shares of the conglomerate’s stock valued at $1,007,000 after buying an additional 554 shares in the last quarter. PNC Financial Services Group Inc. increased its position in Danaher by 10.8% during the 2nd quarter. PNC Financial Services Group Inc. now owns 304,825 shares of the conglomerate’s stock valued at $60,215,000 after buying an additional 29,686 shares in the last quarter. Finally, WASHINGTON TRUST Co raised its stake in Danaher by 15.0% during the second quarter. WASHINGTON TRUST Co now owns 4,771 shares of the conglomerate’s stock valued at $942,000 after buying an additional 623 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 0.6%

Danaher stock opened at $187.34 on Friday. The firm has a market cap of $132.47 billion, a price-to-earnings ratio of 37.17, a PEG ratio of 2.52 and a beta of 0.93. The stock has a fifty day simple moving average of $218.79 and a two-hundred day simple moving average of $215.34. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $242.80. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The firm had revenue of $6.84 billion for the quarter, compared to the consensus estimate of $6.79 billion. During the same period in the prior year, the company posted $2.14 earnings per share. The company’s quarterly revenue was up 4.6% on a year-over-year basis. Equities analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be paid a dividend of $0.40 per share. The ex-dividend date is Friday, March 27th. This represents a $1.60 annualized dividend and a yield of 0.9%. This is an increase from Danaher’s previous quarterly dividend of $0.32. Danaher’s dividend payout ratio (DPR) is currently 25.40%.

Insider Transactions at Danaher

In other news, EVP Gregory M. Milosevich sold 1,320 shares of the firm’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $208.01, for a total transaction of $274,573.20. Following the sale, the executive vice president owned 5,099 shares of the company’s stock, valued at $1,060,642.99. This trade represents a 20.56% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 11.10% of the company’s stock.

Analysts Set New Price Targets

Several research firms have commented on DHR. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a report on Saturday, November 22nd. Jefferies Financial Group raised their price target on Danaher from $255.00 to $265.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. Robert W. Baird set a $251.00 price target on shares of Danaher in a research note on Thursday, January 29th. Leerink Partners increased their price objective on shares of Danaher from $260.00 to $270.00 and gave the company an “outperform” rating in a research report on Friday, January 16th. Finally, KeyCorp restated an “overweight” rating on shares of Danaher in a research note on Thursday, January 29th. Nineteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, Danaher has an average rating of “Moderate Buy” and an average target price of $253.55.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.